jRCT2041210113进行中(未招募)不适用
General drug use-results survey of UPASITA IV Injection Syringe for Dialysis
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 770
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- No limit 至 No limit(—)
- 性别
- All
入选标准
- •Patients with secondary hyperparathyroidism under hemodialysis who are using this drug for the first time
排除标准
- 未提供
研究者
相似试验
招募中
不适用
General drug use-results survey of UPASITA IV Injection Syringe for DialysisJPRN-jRCT2041210113Dept. Pharmacovigilance770
招募中
不适用
uwiq for i.v. injection Drug use-result surveyHemophilia AJPRN-UMIN000047344Fujimoto Pharmaceutical Corp.20
已完成
Unknown
General Drug Use-Results Survey of Onoact [ ventricular fibrillation and hemodynamically ventricular tachycardia]Ventricular arrhythmiasJPRN-jRCT1080225340ONO PHARMACEUTICAL CO., LTD.200
已完成
不适用
33-104 : Drug Use-Results Survey of OPDIVOjRCT2011230029Ono Pharmaceutical Co.,LTD100
已完成
Unknown
33-104 : Drug Use-Results Survey of OPDIVOnresectable advanced/recurrent malignant pleural mesothelioma that has progressed after cancer chemJPRN-jRCT2011230029Kuro Toshihiko100
